UAE Hosts Global Health Leaders at World Local Production Forum 2025
Organised by the World Health Organisation (WHO) with the support of the Emirates Drug Establishment (EDE), the three-day forum is being held at the Abu Dhabi National Exhibition Center under the theme: 'Advancing Local Production for Health Equity, Global Health Security, and Sustainable Development.'
The event brings together heads of state, senior officials, global health leaders, and private sector stakeholders to discuss strategies for strengthening local pharmaceutical manufacturing and improving access to essential medical products worldwide.
In his keynote, Al Owais highlighted the UAE's commitment to equitable healthcare through innovation, advanced technologies, and strategic global partnerships. He noted that hosting the WLPF underscores the UAE's development priorities and its collaboration with WHO to foster sustainable local production.
Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of EDE, emphasised the UAE's dedication to international cooperation and investment in the pharmaceutical sector, aligning trade and health policies to drive global health resilience.
Dr. Fatima Al Kaabi, Director General of EDE, announced that the UAE's pharmaceutical market reached $5.6 billion in 2024, projected to hit $8 billion by 2030. She stressed EDE's focus on regulatory excellence, AI integration, and sustainable practices.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus praised the UAE's leadership, citing the forum as a catalyst for technology transfer, research, and policy reform to empower national healthcare systems.
With high-level panels, regional insights, and innovation-driven sessions, the WLPF 2025 sets a strategic path for inclusive, resilient, and future-ready healthcare production globally.
News Source: Emirates News Agency
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Middle East Eye
3 hours ago
- Middle East Eye
WHO says 12,000 children suffering from acute malnutrition in Gaza
The World Health Organisation on Tuesday asked Israel to allow it to restock medical supplies before it seizes control of Gaza City, in order to enable it to deal with the "catastrophic" health situation in Gaza, AFP reported. "We want to as quickly stock up hospitals... following the news... about an incursion in Gaza," Rik Peeperkorn, WHO's representative in the Palestinian territories, said after Israel announced it would "take control" of Gaza City. Peeperkorn said more than half of all medicines were out of stock. "We all hear about 'more humanitarian supplies are allowed in'. Well, it's not happening yet, or it's happening at a way too low a pace," he added. Peeperkorn said WHO was bringing in fewer supplies than it wanted "due to the cumbersome procedures" and products "still denied" entry - a topic of constant negotiation with the Israeli authorities. Peeperkorn said only 50 percent of hospitals and 38 percent of primary health care centres in Gaza were functioning, and even when functioning, they are only partially functioning. Consequently, bed occupancy has reached 240 percent capacity in the al-Shifa hospital and 300 percent al-Ahli hospital in northern Gaza. "The overall health situation remains catastrophic," he said. "Hunger and malnutrition continue to ravage Gaza. Over 200 people have died from the effects of malnutrition this year. Nearly 12,000 children under five were identified to be suffering from acute malnutrition in July - the highest monthly figure recorded to date in Gaza, Peeperkorn said. This figure includes 2,562 children suffering from severe acute malnutrition, of whom 40 were hospitalised at stabilisation centres. Israel has severely restricted the entry of food, water, medicine, and fuel, with the UN warning that famine was imminent.
ARN News Center
4 days ago
- ARN News Center
UAE continues Gaza airdrops, expands ground aid deliveries
The UAE has continued its humanitarian mission to support Palestinians in the Gaza Strip, conducting its 65th airdrop of relief supplies and dispatching 21 aid trucks via designated land crossings. The mission - carried out in coordination with Jordan and with the participation of Germany and Belgium - targeted areas inaccessible by land due to ongoing conflict and deteriorating field conditions. Under the UAE's Birds of Goodness initiative as part of Operation Chivalrous Knight 3, the total amount of aid delivered by air has exceeded 3,800 tonnes, with deliveries through land crossing 500 tonnes. These efforts come amid alarming warnings from international health authorities. On Thursday, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), reported that the enclave is now witnessing its highest monthly rate of acute malnutrition among children since the start of Israel's war on Gaza with hunger-related deaths continuing to rise.
Zawya
4 days ago
- Zawya
Kenya certified for elimination of human African trypanosomiasis (sleeping sickness)
The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone. HAT is the second neglected tropical disease (NTD) to be eliminated in Kenya: the country was certified free of Guinea worm disease in 2018. 'I congratulate the government and people of Kenya on this landmark achievement,' said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 'Kenya joins the growing ranks of countries freeing their populations of human African trypanosomiasis. This is another step towards making Africa free of neglected tropical diseases'. HAT a vector-borne disease caused by the blood parasite Trypanosoma brucei. It is transmitted to humans through the bites of tsetse flies that have acquired the parasites from infected humans or animals. Rural populations dependent on agriculture, fishing, animal husbandry or hunting are most at risk of exposure. As the name indicates, HAT is transmitted only on the African continent. The disease exists in two forms, gambiense and rhodesiense. The rhodesiense form, which is found in eastern and southern Africa, is the only one present in Kenya. It is caused by Trypanosoma brucei rhodesiense (r-HAT) and progresses rapidly invading multiple organs including the brain. Without treatment, it is fatal within weeks. Kenya's progress 'This validation marks a major public health milestone for Kenya, as we celebrate the elimination of a deadly disease in our country. The achievement will not only protect our people but also pave the way for renewed economic growth and prosperity,' said Dr Aden Duale, Kenya's Cabinet Secretary for Health. 'This follows many years of dedication, hard work and collaboration'. The first cases of HAT in Kenya were detected in the early 20 century. Since then, Kenya has engaged in consistent control activities, without indigenous new cases reported for over 10 years. The last autochthonous case was detected in 2009, and the last two exported cases, infected in the Masai Mara National Reserve, were detected in 2012. Recently, Kenya strengthened HAT surveillance in 12 health facilities in six historically endemic counties to act as sentinel sites. They were equipped with diagnostic tools and had their clinical personnel trained on diagnostic procedures, including the most sensitive and practical tests for r-HAT. The country also actively monitors the control and surveillance of tsetse flies and animal trypanosomiasis, both within and beyond the historical HAT endemic areas, supported by the national veterinary health authorities and the Kenya Tsetse and Trypanosomiasis Eradication Council (KENTTEC). These activities and the related data provide supplementary backing to the claim of HAT elimination as a public health problem. 'This key milestone reflects Kenya's efforts and commitment over many years, as a collaboration between national and county governments, national research institutions, development partners and affected communities,' said Dr Patrick Amoth, EBS, Director General Health, Ministry of Health, Kenya. 'The country remains fully committed to sustain the quality of care and surveillance in line with WHO's recommendations'. Supported by WHO and partners, including FIND, Kenya's HAT elimination programme will now implement a post-validation surveillance plan to detect any potential resurgence or reintroduction of transmission. WHO continues to support ongoing monitoring in previously affected areas and maintains a stock of medicines to ensure rapid treatment of possible future cases, thanks to donations from Bayer AG and Sanofi. 'This success was made possible by the Ministry of Health's leadership, the dedication of health workers in areas at risk and the support from key partners,' said Dr Abdourahmane Diallo, WHO Representative to Kenya. 'WHO is proud to have contributed to this achievement and encourages all stakeholders to remain involved in post-validation monitoring'. Progress in global HAT elimination A total of 57 countries have eliminated at least one NTD. Of these, 10 (including Kenya) have successfully eliminated HAT as a public health problem. The other countries that have reached this milestone are Benin, Chad, Côte d'Ivoire, Equatorial Guinea, Ghana, Guinea, Rwanda, Togo and Uganda. Distributed by APO Group on behalf of World Health Organization - Kenya.
